Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion type Assertion NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_head.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion description "[Differential expression of a combined set of seven gene transcripts (insulin-like growth factor-binding protein 7, sorting nexin 16, chondroitin sulfate proteoglycan 6, and cathepsin D, chromodomain helicase DNA-binding protein 2, nell-like 2, and tumor necrosis factor receptor superfamily member 7) was able to discriminate bladder cancer from control samples with a sensitivity of 83% (95% confidence interval, 67-93%) and a specificity of 93% (95% confidence interval, 76-99%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_provenance.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion evidence source_evidence_literature NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_provenance.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion SIO_000772 16740760 NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_provenance.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion wasDerivedFrom befree-20140225 NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_provenance.
- NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_assertion wasGeneratedBy ECO_0000203 NP753798.RAd8dkGXdFKH9q8-UuEwMkRzo7OENAe_UtFRTcT4O-WgI130_provenance.